AT
Anika Therapeutics Inc
🇺🇸XNAS.ANIKUnited StatesHealthcare
$21.08USDup +0.22 (+1.05%)OpenDelayed6:03 PM
Price$21.08+0.22 (+1.05%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0352551081
- CUSIP
- 035255108
Company
- Employees
- 235
- Headquarters
- Bedford, United States
- Website
- https://www.anika.com
- CEO
- Mr. Stephen D. Griffin
Market
- Shares outstanding
- 13.4M
- Market cap
- $282.11M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $279.17M
- EPS LTM
- -$0.28
- P/E LTM
- -74.82calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $120.65M+31.36%up year on year
- Net income
- -$3.78M+93.76%up year on year
- Gross margin
- 62.16%+7.63%up year on year
- Free cash flow
- $562K+149.52%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.